Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/KINTOR-PHARMACEUTICAL-LIM-111325374/news/Kintor-Pharma-Announces-Completion-of-Subject-Enrollment-in-Phase-III-Clinical-Trial-of-KX-826-for-T-43366278/?utm_source=whatsapp&utm_medium=social&utm_campaign=share